Trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['gastric', 'rux,(-crux),(-trux)', 'destiny,gastric02', '1205mo', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'able,(-kable),(-eable)']
an interesting abstract at #esmo2022! #destiny-gastric02: a phase ii single-arm trial of #trastuzumab #deruxtecan in pts w/ #her2+ unresectable/metastatic gastric/gej cancer who progressed on or after #trastuzumab regimen! 10/09/2022 1205mo #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB